Aller au contenu principal
Accès ouvert déclaré 2023 article

P1004: ACTIVATING MUTATIONS IN JAK2 AND CALR DIFFERENTIALLY AFFECT INTRACELLULAR CALCIUM LEVELS AND CALCIUM FLUX

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : de. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Topic: 15. Myeloproliferative neoplasms - Biology & Translational Research Background: In myeloproliferative neoplasms (MPNs), mutations in Janus kinase 2 (JAK2), calreticulin (CALR), and the thrombopoietin receptor (MPL) activate common Janus kinase/signal transducer and activator of transcription signaling (JAK/STAT) pathways. These mutations confer hypersensitivity in cytokine-induced proliferation and drive clonal expansion of hematopoietic progenitor cells. However, the exact mechanisms of action of these mutants have not been fully comprehended. Calcium (Ca2+) is an important intracellular secondary messenger, which regulates diverse essential cellular functions, like activation of integrins, cell migration, exocytosis and many more. One major Ca2+ influx pathway in many cell types is store-operated calcium entry (SOCE) through calcium release-activated calcium (CRAC) channels. Although, Phospholipase Cγ1 (PLCγ1) which controls Ca2+ signaling pathways, has been implicated in the formation of early erythropoiesis, the role of mutated JAK2 and CALR on SOCE has been remained elusive. Aims: The purpose of this study was to determine the effect of JAK2-V617F and CALR mutations on SOCE and key signaling pathways in the absence or presence of erythropoietin (EPO) or thrombopoietin (TPO), respectively. Methods: 32D cells (JAK2WT/EpoR, JAK2-V617F/EpoR; CALRWT/MPL, CALR-ins5/MPL and del52/MPL) were labeled with Fura-2 AM for 30 minutes and then seeded in 0.01% poly-L-lysine pre-coated 96-well plates. Intracellular Ca2+ measurements were performed using Synergy H1 plate reader. Total Ca2+ measurement time frame was from 0sec to 1080sec, where basal Ca2+ concentration was measured between 0sec-108sec. Subsequently, cells were stimulated with EPO/TPO in Ca2+-free Ringer solution and Ca2+ measurement was performed from 109sec-594sec (store depletion), followed by addition of 2mM Ca2+ Ringer solution to induce SOCE where the measurement was acquired from 595sec-1080sec. Fura-2 emission ratios (F340/380) were quantified by analyzing the integrated Ca2+ signal. Results: Upon EPO stimulation, SOCE measured as area under the curve (AUC) was significantly increased in 32D JAK2V617F cells (p=0.035) as compared to 32D-WT cells. Conversely, under unstimulated conditions 32D-WT cells (p=0.001) showed significantly higher basal levels of cytosolic Ca2+ compared to 32D JAK2-V617F cells. Furthermore, we measured the Ca2+ levels following store depletion and SOCE in TPO stimulated CALR cells. The Ca2+ concentration during store depletion (Max peak: p=0.04; AUC: p=0.05) and SOCE (Max peak: p=0.06; AUC: p=0.07) was higher in WT CALR cells in comparison with CALR-ins5 and del52 cells. To dissect the underlying molecular mechanisms, we analyzed the key downstream components of EPO/JAK2 and TPO/MPL signaling pathways. Upon stimulation, essential elements of the Ca2+ signaling pathways such as PLCγ1 and IP3, were found to be activated in these cell lines. A substantial change in the dynamics of phosphorylated states of PLCγ1, IP3, STAT3, STAT5, AKT, MEK, and ERK was found in 32D JAK2-V617F and CALR mutated cells. Summary/Conclusion: The mutations in JAK2 and CALR differentially affect store-operated calcium entry. We here provide novel evidence that the JAK2-V617F mutation induces an essential change in the regulatory mechanism of EpoR/JAK2-dependent intracellular Ca2+ homeostasis upon EPO stimulation. This affects both basal and SOCE induced Ca2+ levels, cytokine dependent PLCγ1 signalling pathways, and cellular proliferation. These findings explain the clinically observed differential response of JAK2V617F vs. WT progenitor cells to cytokines in MPN. Keywords: Calcium, Intracellular signaling, Myeloproliferative disorder

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
P1004: ACTIVATING MUTATIONS IN JAK2 AND CALR DIFFERENTIALLY AFFECT INTRACELLULAR CALCIUM LEVELS AND CALCIUM FLUX
Date Crossref
01/08/2023
Éditeur
Wiley
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Otto-von-Guericke-Universität Magdeburg pays non établi dans la notice
    Université ou école supérieure
  • RWTH Aachen University pays non établi dans la notice
    Université ou école supérieure
  • Medical Faculty Institute for Molecular and Clinical Immunology pays non établi dans la notice
    Université ou école supérieure
  • Otto-von-Guericke University Magdeburg Medical Center pays non établi dans la notice
    Université ou école supérieure
  • Faculty of Medicine Department of Hematology pays non établi dans la notice
    Université ou école supérieure

Otto-von-Guericke-Universität Magdeburg, RWTH Aachen University et Institute for Molecular and Clinical Immunology — Medical Faculty, avec 2 autres affiliations.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Myeloproliferative Neoplasms: Diagnosis and Treatment

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.